BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2297841)

  • 1. Prostaglandin redirection by thromboxane synthetase inhibition. Attenuation of myocardial stunning in canine heart.
    Farber NE; Gross GJ
    Circulation; 1990 Jan; 81(1):369-80. PubMed ID: 2297841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in postischemic recovery in the stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Am Heart J; 1987 Nov; 114(5):1086-95. PubMed ID: 3673875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals.
    Przyklenk K
    Circulation; 1994 Mar; 89(3):1272-81. PubMed ID: 8124816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
    Pieper GM; Farber NE; Gross GJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):13-22. PubMed ID: 3054935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion.
    Farber NE; Gross GJ
    Am Heart J; 1989 Jul; 118(1):17-24. PubMed ID: 2741783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart.
    Farber NE; Vercellotti GM; Jacob HS; Pieper GM; Gross GJ
    Circ Res; 1988 Aug; 63(2):351-60. PubMed ID: 3396156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclooxygenase blockade on the beneficial actions of nicorandil in the stunned myocardium of dogs.
    Gross GJ; Pieper GM
    Pharmacology; 1989; 38(6):341-51. PubMed ID: 2530592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
    Yao Z; Gross GJ
    Circulation; 1993 Jul; 88(1):235-44. PubMed ID: 8319338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
    Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of iloprost in the stunned canine myocardium.
    Farber NE; Pieper GM; Thomas JP; Gross GJ
    Circ Res; 1988 Feb; 62(2):204-15. PubMed ID: 2448057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial actions of amlodipine in the multiple-stunned canine myocardium.
    Gross GJ; Pieper GM
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):67-75. PubMed ID: 1533534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning.
    Auchampach JA; Maruyama M; Cavero I; Gross GJ
    Circulation; 1992 Jul; 86(1):311-9. PubMed ID: 1301066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning does not attenuate myocardial stunning.
    Ovize M; Przyklenk K; Hale SL; Kloner RA
    Circulation; 1992 Jun; 85(6):2247-54. PubMed ID: 1591839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts.
    Miyamae M; Fujiwara H; Kida M; Yokota R; Tanaka M; Katsuragawa M; Hasegawa K; Ohura M; Koga K; Yabuuchi Y
    Circulation; 1993 Jul; 88(1):223-34. PubMed ID: 8319337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs.
    Yao Z; Elliott GT; Gross GJ
    Pharmacology; 1995 Sep; 51(3):152-9. PubMed ID: 7501700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term myocardial preservation: thromboxane production and coronary resistance.
    van Rijk GL; Foegh M; Ramwell PW; Goldman M; Lower RR
    J Surg Res; 1983 Nov; 35(5):417-20. PubMed ID: 6688844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.